世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti–vascular Endothelial Growth Factor Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0421
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、抗血管内皮増殖因子（抗VEGF）療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抽出注入、プリチャージ注入）、用途別市場規模（黄斑変性症、眼浮腫、ブドウ膜炎、網膜静脈閉塞症）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・抗血管内皮増殖因子（抗VEGF）療法の市場動向
・企業の競争状況、市場シェア
・抗血管内皮増殖因子（抗VEGF）療法の種類別市場規模（抽出注入、プリチャージ注入）
・抗血管内皮増殖因子（抗VEGF）療法の用途別市場規模（黄斑変性症、眼浮腫、ブドウ膜炎、網膜静脈閉塞症）
・抗血管内皮増殖因子（抗VEGF）療法の北米市場規模2016-2027（アメリカ、カナダ）
・抗血管内皮増殖因子（抗VEGF）療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗血管内皮増殖因子（抗VEGF）療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗血管内皮増殖因子（抗VEGF）療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗血管内皮増殖因子（抗VEGF）療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Regeneron Pharmaceuticals (Eylea)、Genentech、Kanghong Pharmaceutical）
・結論

Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market
The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti–vascular Endothelial Growth Factor Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti–vascular Endothelial Growth Factor Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti–vascular Endothelial Growth Factor Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti–vascular Endothelial Growth Factor Therapy market.

Global Anti–vascular Endothelial Growth Factor Therapy Scope and Market Size
Anti–vascular Endothelial Growth Factor Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti–vascular Endothelial Growth Factor Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Extraction Injection
Precharge Injection

Segment by Application
Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Regeneron Pharmaceuticals (Eylea)

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Extraction Injection
1.2.3 Precharge Injection
1.3 Market by Application
1.3.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Macular Degeneration
1.3.3 Nacular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Perspective (2016-2027)
2.2 Anti–vascular Endothelial Growth Factor Therapy Growth Trends by Regions
2.2.1 Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti–vascular Endothelial Growth Factor Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Anti–vascular Endothelial Growth Factor Therapy Industry Dynamic
2.3.1 Anti–vascular Endothelial Growth Factor Therapy Market Trends
2.3.2 Anti–vascular Endothelial Growth Factor Therapy Market Drivers
2.3.3 Anti–vascular Endothelial Growth Factor Therapy Market Challenges
2.3.4 Anti–vascular Endothelial Growth Factor Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Revenue
3.1.1 Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Revenue (2016-2021)
3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti–vascular Endothelial Growth Factor Therapy Revenue
3.4 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio
3.4.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2020
3.5 Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Area Served
3.6 Key Players Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
3.7 Date of Enter into Anti–vascular Endothelial Growth Factor Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Type
4.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Type (2016-2021)
4.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2022-2027)

5 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Application
5.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Application (2016-2021)
5.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
6.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
6.2.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
6.2.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
6.2.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
6.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
6.3.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
6.3.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
6.3.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
6.4 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
6.4.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
6.4.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
7.2.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
7.2.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
7.2.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
7.3.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
7.3.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
7.3.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
7.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
7.4.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
7.4.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
8.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
8.2.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
8.3.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region
8.4.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
9.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
9.2.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
9.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
9.3.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
9.4 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
9.4.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
10.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
10.2.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
10.3.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
10.4.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Company Details
11.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Introduction
11.1.4 Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
11.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
11.2 Genentech
11.2.1 Genentech Company Details
11.2.2 Genentech Business Overview
11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Introduction
11.2.4 Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
11.2.5 Genentech Recent Development
11.3 Kanghong Pharmaceutical
11.3.1 Kanghong Pharmaceutical Company Details
11.3.2 Kanghong Pharmaceutical Business Overview
11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Introduction
11.3.4 Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
11.3.5 Kanghong Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Extraction Injection
Table 3. Key Players of Precharge Injection
Table 4. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Regions (2016-2021)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Regions (2022-2027)
Table 10. Anti–vascular Endothelial Growth Factor Therapy Market Trends
Table 11. Anti–vascular Endothelial Growth Factor Therapy Market Drivers
Table 12. Anti–vascular Endothelial Growth Factor Therapy Market Challenges
Table 13. Anti–vascular Endothelial Growth Factor Therapy Market Restraints
Table 14. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players (2016-2021)
Table 16. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2020)
Table 17. Ranking of Global Top Anti–vascular Endothelial Growth Factor Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
Table 21. Date of Enter into Anti–vascular Endothelial Growth Factor Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Regeneron Pharmaceuticals (Eylea) Company Details
Table 62. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 63. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product
Table 64. Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021) & (US$ Million)
Table 65. Regeneron Pharmaceuticals (Eylea) Recent Development
Table 66. Genentech Company Details
Table 67. Genentech Business Overview
Table 68. Genentech Anti–vascular Endothelial Growth Factor Therapy Product
Table 69. Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021) & (US$ Million)
Table 70. Genentech Recent Development
Table 71. Kanghong Pharmaceutical Company Details
Table 72. Kanghong Pharmaceutical Business Overview
Table 73. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product
Table 74. Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021) & (US$ Million)
Table 75. Kanghong Pharmaceutical Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Type: 2020 VS 2027
Figure 2. Extraction Injection Features
Figure 3. Precharge Injection Features
Figure 4. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Application: 2020 VS 2027
Figure 5. Macular Degeneration Case Studies
Figure 6. Nacular Edema Case Studies
Figure 7. Uveitis Case Studies
Figure 8. Retinal Vein Occlusion Case Studies
Figure 9. Anti–vascular Endothelial Growth Factor Therapy Report Years Considered
Figure 10. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Regions (2022-2027)
Figure 14. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players in 2020
Figure 15. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2020
Figure 17. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2016-2027)
Figure 21. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2016-2027)
Figure 22. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2016-2027)
Figure 23. United States Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2016-2027)
Figure 27. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2016-2027)
Figure 28. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2016-2027)
Figure 29. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2016-2027)
Figure 39. China Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2016-2027)
Figure 47. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2016-2027)
Figure 48. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2016-2027)
Figure 49. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2016-2027)
Figure 55. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Regeneron Pharmaceuticals (Eylea) Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
Figure 59. Genentech Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
Figure 60. Kanghong Pharmaceutical Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Global Anti–vascular Endothelial Growth Factor Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0421 2021年4月 98Pages
QYResearch社発行の本調査資料では、抗血管内皮増殖因子（抗VEGF）療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抽出注入、プリチャージ注入）、用途別市場規模（黄斑変性症、眼浮腫、ブドウ膜炎、網膜静脈閉塞症）、主要地域別市場規模（...

世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年）

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0420 2021年4月 93Pages
QYResearch社発行の本調査資料では、抗血管内皮増殖因子（抗VEGF）薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アゴニスト、アロステリックモジュレーター、キナーゼ阻害剤、モノクローナル抗体、その他）、用途別市場規模（病院、クリニッ...

世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年）

世界の高密度焦点式超音波（HIFU）療法市場規模・現状・予測（2021年-2027年）

Global High Intensity Focused Ultrasound (HIFU) Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z2825 2021年4月 97Pages
QYResearch社発行の本調査資料では、高密度焦点式超音波（HIFU）療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（超音波治療、止血）、用途別市場規模（診断センター、病院、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の血友病A・B組換え因子補充療法市場規模・現状・予測（2021年-2027年）

Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z2770 2021年4月 92Pages
QYResearch社発行の本調査資料では、血友病A・B組換え因子補充療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A、血友病B）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の網膜血管閉塞市場規模・現状・予測（2021年-2027年）

Global Retinal Vascular Occlusion Market Size, Status and Forecast 2021-2027
QYR2104Z5021 2021年4月 92Pages
QYResearch社発行の本調査資料では、網膜血管閉塞のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗血管内皮増殖因子（VEGF）、副腎皮質ステロイド、抗凝血性、線維素溶解性、その他）、用途別市場規模（病院・診療所、研究・学術、その他）、主...

世界の内皮機能障害市場規模・現状・予測（2021年-2027年）

Global Endothelial Dysfunction Market Size, Status and Forecast 2021-2027
QYR2104Z2164 2021年4月 92Pages
QYResearch社発行の本調査資料では、内皮機能障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（西洋医学治療、漢方治療）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の抗炎症療法市場規模・現状・予測（2021年-2027年）

Global Anti-inflammatory Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0396 2021年4月 90Pages
QYResearch社発行の本調査資料では、抗炎症療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗炎症生物製剤、非ステロイド性抗炎症薬、その他）、用途別市場規模（呼吸器疾患、関節炎、消化器内科、皮膚科、その他）、主要地...

世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年）

Global Antihemophilic Factor & von Willebrand Factor Complex Market Size, Status and Forecast 2021-2027
QYR2104Z0392 2021年4月 85Pages
QYResearch社発行の本調査資料では、抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（5ml、10ml、15ml）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北...

世界の凝固因子市場規模・現状・予測（2021年-2027年）

Global Clotting Factor Market Size, Status and Forecast 2021-2027
QYR2104Z1391 2021年4月 95Pages
QYResearch社発行の本調査資料では、凝固因子のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米...

世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
世界の網膜血管閉塞市場規模・現状・予測（2021年-2027年） Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot. The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and …
世界の黄斑変性症（AMD）・その他網膜疾患市場規模・現状・予測（2021年-2027年） Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands. Market Analysis and Insights: Global…